early detection
High PRS Equivalent to Rare Monogenic Risk Variants in Certain Cases in UK Biobank Population
Premium
Current genetic screening programs might miss people with high disease risk as determined by PRS, who likely outnumber pathogenic mutation carriers.
Aitiologic Developing Liquid Biopsy Assay for Tissue-of-Origin Analysis, Early Disease Detection
Premium
The Austrian startup's assay and software, which are early in R&D, promise to profile both the genetic and epigenetic signatures of cell-free DNA from blood samples.
Investigators are trialing methods to boost sensitivity for certain cancers, and assessing measures of how tests may impact clinical care in certain screening subpopulations.
Cancer Diagnostics Firm Syantra Raises $3.6M in Series A-1 Round
The University of Calgary spinout aims to commercialize a liquid biopsy test that measures mRNA biomarkers for the early detection of breast cancer.
Lucid Diagnostics Partners With Front Line Mobile to Promote Esophageal Cancer Test
Working with the first responder medical care provider, Lucid is planning high-volume testing events among firefighters and other frontline workers with elevated risk.